Loading clinical trials...
Loading clinical trials...
Development of an International Multicenter Registry of Patients With Monogenic and Polygenic Autoinflammatory Diseases Aimed at Clinical and Therapeutical Data Collection and Analysis
Conditions
Interventions
No intervention is foreseen by the protocol.
Locations
112
Algeria
University Algiers 1
Algiers, Algeria
Université M'Hamed Bougara de Boumerdas
Boumerdas, Algeria
Flinders University
Adelaide, Australia
University of Adelaide
Adelaide, Australia
Antwerp University Hospital
Antwerp, Belgium
Hospital das Clinicas da Faculdade de Medicina HCFMUSP
São Paulo, Brazil
Start Date
August 6, 2020
Primary Completion Date
August 6, 2026
Completion Date
August 6, 2030
Last Updated
July 10, 2025
NCT06849908
NCT06729112
NCT05142995
NCT05098678
NCT03554161
NCT00866359
Lead Sponsor
University of Siena
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions